Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Adynxx
100 Pine Street, Suite 500
San Francisco, CA 94111
Phone: 415-512-7740
http://www.adynxx.com/index_files/Page402.htm

Adynxx is a clinical-stage pharmaceutical company developing a transformative technology platform addressing pain at its molecular roots - preventing the development of pain following surgery and resolving established chronic pain conditions. Adynxx's unique approach is to transform pain management by approaching pain as a disease rather than a symptom. Adynxx's lead compound, AYX1, is an investigational drug designed to reduce acute post-surgical pain and prevent the transition to persistent or chronic pain with a single administration at the time of surgery.

Key Contact
NameTitleE-Mail
Rick OrrCEOrorr@adynxx.com


Funding Events
DateAmountTypeInvestors
01/11/17$16,000,000Series B Domain Associates
TPG Biotech
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.